Time to response to citalopram treatment for agitation in Alzheimer's disease

BACKGROUND: Agitation is a common and significant problem in Alzheimer’s disease (AD). In the recent Citalopram for Agitation in Alzheimer’s Disease (CitAD) study, citalopram was efficacious for the treatment of AD agitation. Here we examined the time course and predictors of response to treatment....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Geriatr Psychiatry
Main Authors: Weintraub, Daniel, Drye, Lea T., Porsteinsson, Anton P., Rosenberg, Paul B., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Schneider, Lon S., Shade, David M., Yesavage, Jerome, Lyketsos, Constantine G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4653092/
https://ncbi.nlm.nih.gov/pubmed/26238225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2015.05.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados